marijuana stocks news

Form 8-K for LEXARIA BIOSCIENCE CORP.


7-Jun-2016

Regulation FD Disclosure, Financial Statements and Exhibits

Item 7.01 Regulation FD DisclosureA copy of the news release announcing our intention to complete an equity financing of CDN$100,000 is filed as exhibit 99.1 to this current report and is hereby incorporated by reference.

 

Item 9.01 Financial Statements and Exhibits99.1 Press Release dated May 31, 2016


– 2 –

 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

GW Pharmaceuticals plc (GWPH) and U.S. Subsidiary Greenwich Biosciences to Present Data on Epidiolex®

GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data on Epidiolex®…

$IMLFF Qualifies for Electronic Trading in the U.S.

InMed Pharmaceuticals Qualifies for Electronic Trading in the U.S. — Company Now…

Greenlane Holdings, Inc. (GNLN) Announces $32 Million Registered Direct Offering

Greenlane Holdings Announces $32 Million Registered Direct Offering Priced At-The-Market Under Nasdaq…

TILT Holdings Inc. (TLLTF) Receives Approval to Trade on the NEO Exchange

TILT Receives Approval to Trade on the NEO Exchange TILT Holdings Inc.…